Cite
HARVARD Citation
Shirahata, A. et al. (n.d.). A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. Haemophilia. pp. 853-860. [Online].